A. Hehr et al., SER(165) OF TRANSMEMBRANE HELIX-IV IS NOT INVOLVED IN THE INTERACTIONOF CATECHOLAMINES WITH THE ALPHA-2A-ADRENOCEPTOR, Pharmacology, 55(1), 1997, pp. 18-24
Molecular modeling studies have predicted that the beta-hydroxyl group
of the catecholamines interacts with the beta(2)-adrenoceptor at the
serine residue at position 165 (Ser(165)) located on transmembrane hel
ix IV; however, this has not been confirmed by site-directed mutagenes
is. It has been inferred that this site, which is conserved in all of
the nine known alpha- and beta-adrenoceptor subtypes, is also involved
in the interaction of catecholamines with the az,alpha(2a)-adrenocept
or. To test the hypothesis that the beta-hydroxyl group of the catecho
lamines interacts with Ser(165) of the alpha(2a)-adrenoceptor, we prep
ared a mutant alpha(2a)-adrenoceptor where Ser(165) was mutated to ala
nine. Mutation of Ser(165) of the alpha(2a)-adrenoceptor to alanine ha
d no effect on the affinity of dopamine (which lacks the beta-hydroxyl
group) or either enantiomer of norepinephrine or epinephrine (bath of
which possess the beta-hydroxyl group), indicating that Ser(165) is n
ot involved in the interaction of the catecholamines with the alpha(2a
)-adrenoceptor. We have previously shown that mutation of Ser(90), loc
ated in transmembrane helix II, to either alanine or cysteine produces
a selective reduction in the affinity of the (-)-enantiomers of the c
atecholamines for the alpha(2a)-adrenoceptor, with no effect on the ()-enantiomers or the corresponding beta-desoxy analogs. This is consis
tent with the known stereoselectivity involved in the interactions of
catecholamines with the alpha(2a)-adrenoceptor. The results of the pre
sent investigation indicate that Ser(165) is not involved in the inter
action of catecholamines with the alpha(2a)-adrenoceptor. Because all
known alpha-adrenoceptor subtypes have a serine residue at a position
corresponding to Ser(90) of the alpha(2a)-adrenoceptor, it would appea
r that this site represents an important point for attachment of the b
eta-hydroxyl group of catecholamines.